Skip to main content

Table 1 General clinical features

From: Effect of changing treatment to high-flux hemodialysis (HFHD) on mortality in patients with long-term low flux hemodialysis (LFHD): a propensity score matched cohort study

Groups HFHD group LFHD group p
Gender (male/female) 76/38 38/19 1.000
Age (years) 50.1 ± 9.8 49.3 ± 12.7 0.055
Primary disease   0.836
 Chronic glomerulonephritis 33 63  
 diabetic nephropathy 6 12  
 Hypertensive renal damage 13 29  
 Other diseases 5 10  
 Dialysis age (month) 83.2 ± 30.4 79.2 ± 45.3 0.243
Laboratory examination
 Hemoglobin (g/l) 112.79 ± 15.61 112.99 ± 13.86 0.973
 Albumin (g/dl) 41.32 ± 2.05 41.35 ± 2.33 0.196
 Blood phosphorus (mmol/l) 2.16 ± 0.54 2.14 ± 0.58 0.798
 KT/V 1.35 ± 0.25 1.36 ± 0.22 0.813
 Cardiovascular complications 4 2 1.00
\